![Athena](https://www.pharmacompass.com/image/flap/athena-corp-ad-w13-desktop-headergif-7165.gif)
![Athena](https://www.pharmacompass.com/image/flap/athena-corp-ad-w13-mob-headergif-22383.gif)
X
19
Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TEDUGLUTIDE RECOMBINANT, with a corresponding application number 203441 and regulatory information .
proudly manufactured in the
approval since 2012-12-21
Takeda Pharmaceutical's GATTEX KIT POWDER;SUBCUTANEOUS, medication with 5MG/VIAL of TEDUGLUTIDE RECOMBINANT.